Traws Pharma TRAW
NASDAQ TRAW
$0.54 +0.02 (+3.12%)
As of: Aug 21, 2026 · 3:59 PM EDT

Traws Pharma (TRAW) Tax Provisions (2013)

Traws Pharma (TRAW) posted quarterly Tax Provisions of $3000.0 for Q4 2013, down 99.31% quarter-over-quarter from $432000.0 in Q3 2013.

Traws Pharma (TRAW) Tax Provisions (2013) Analysis & Trends

Traws Pharma (TRAW) has reported Tax Provisions for 1 consecutive years, with $3000.0 the latest figure, recorded in Q4 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 292.00 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 230.90 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 59.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 15.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 75.45 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 13.31 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -90.33 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.90 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Traws Pharma 5.66 Mn 639,491.99 - -

Historic Data

Download Data
DateValue
Dec 31, 2013 3,000.00
Sep 30, 2013 432,000.00